Yazar "Beş, C." için listeleme
-
Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data
Kimyon, G.; Kalyoncu, U.; Kiraz, S.; Beş, C.; Coşkun, N.; Yağız, B.; Ertenli, I; Mercan, Rıdvan (Clinical & Exper Rheumatology, 2021)Objective To determine the real-life efficacy, safety, and drug-retention rates of leflunomide (LEF) or methotrexate (MTX) as a synthetic DMARD used in combination with biological DMARDs for rheumatoid arthritis (RA). ... -
FACTORS ASSOCIATED WITH HIP INVOLVEMENT AND ITS IMPACT ON TREATMENT DECISION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS; TREASURE EXPERIENCE
Ediboğlu, E. Durak; Kalyoncu, U.; Solmaz, D.; Kaşifoğlu, T.; Tekgöz, E.; Beş, C.; Erden, A.; Mercan, Rıdvan; Emmungil, Hakan (Bmj Publishing Group, 2022)[Abstract Not Available]